DZ Bank
VRTX icon

DZ Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

DZ Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$7.89M – 1081
2022
Q1 		$7.89M Buy
+30,000
New +$7.12M 0.01% 410

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DZ Bank's VRTX Position: Q2 2026 in Review

DZ Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 1.4% in Q2 2026, selling an estimated $2.3M and leaving 359,332 shares worth $178M. The position accounts for 0.14% of the portfolio, ranked #116.

DZ Bank first reported a position in VRTX in Q4 2017 and has held it in 35 quarters since. The position peaked at $563M in Q3 2020. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • DZ Bank held 359,332 shares of Vertex Pharmaceuticals worth $178M as of Q2 2026.
  • DZ Bank sold 5,181 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.3M.
  • Vertex Pharmaceuticals made up 0.14% of DZ Bank's portfolio in Q2 2026, its #116 holding.
  • DZ Bank first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
  • DZ Bank's Vertex Pharmaceuticals position peaked at $563M in Q3 2020.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.